Journal of Fungi (Jun 2022)

<i>Aspergillus</i> Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments

  • Alisha Khambati,
  • Robert Emery Wright ,
  • Susmita Das,
  • Shirisha Pasula,
  • Alejandro Sepulveda,
  • Francis Hernandez,
  • Mamta Kanwar,
  • Pranatharthi Chandrasekar,
  • Ashok Kumar

DOI
https://doi.org/10.3390/jof8070656
Journal volume & issue
Vol. 8, no. 7
p. 656

Abstract

Read online

Fungal endophthalmitis is one of the leading causes of vision loss worldwide. Post-operative and traumatic injuries are major contributing factors resulting in ocular fungal infections in healthy and, more importantly, immunocompromised individuals. Among the fungal pathogens, the Aspergillus species, Aspergillus fumigatus, continues to be more prevalent in fungal endophthalmitis patients. However, due to overlapping clinical symptoms with other endophthalmitis etiology, fungal endophthalmitis pose a challenge in its diagnosis and treatment. Hence, it is critical to understand its pathobiology to develop and deploy proper therapeutic interventions for combating Aspergillus infections. This review highlights the different modes of Aspergillus transmission and the host immune response during endophthalmitis. Additionally, we discuss recent advancements in the diagnosis of fungal endophthalmitis. Finally, we comprehensively summarize various antifungal regimens and surgical options for the treatment of Aspergillus endophthalmitis.

Keywords